149 related articles for article (PubMed ID: 19196660)
1. Pivotal role of mast cells in pruritogenesis in patients with myeloproliferative disorders.
Ishii T; Wang J; Zhang W; Mascarenhas J; Hoffman R; Dai Y; Wisch N; Xu M
Blood; 2009 Jun; 113(23):5942-50. PubMed ID: 19196660
[TBL] [Abstract][Full Text] [Related]
2. Elevated levels of mast cells are involved in pruritus associated with polycythemia vera in JAK2V617F transgenic mice.
Jin X; Zhao W; Kirabo A; Park SO; Ho WT; Sayeski PP; Zhao ZJ
J Immunol; 2014 Jul; 193(2):477-84. PubMed ID: 24920845
[TBL] [Abstract][Full Text] [Related]
3. Involvement of mast cells by the malignant process in patients with Philadelphia chromosome negative myeloproliferative neoplasms.
Wang J; Ishii T; Zhang W; Sozer S; Dai Y; Mascarenhas J; Najfeld V; Zhao ZJ; Hoffman R; Wisch N; Xu M
Leukemia; 2009 Sep; 23(9):1577-86. PubMed ID: 19387466
[TBL] [Abstract][Full Text] [Related]
4. Characterization of human decidual mast cells and establishment of a culture system.
Matsuno T; Toyoshima S; Sakamoto-Sasaki T; Kashiwakura JI; Matsuda A; Watanabe Y; Azuma H; Kawana K; Yamamoto T; Okayama Y
Allergol Int; 2018 Sep; 67S():S18-S24. PubMed ID: 29784282
[TBL] [Abstract][Full Text] [Related]
5. The 2001 World Health Organization and updated European clinical and pathological criteria for the diagnosis, classification, and staging of the Philadelphia chromosome-negative chronic myeloproliferative disorders.
Michiels JJ; De Raeve H; Berneman Z; Van Bockstaele D; Hebeda K; Lam K; Schroyens W
Semin Thromb Hemost; 2006 Jun; 32(4 Pt 2):307-40. PubMed ID: 16810609
[TBL] [Abstract][Full Text] [Related]
6. Human mast cells arise from a common circulating progenitor.
Maaninka K; Lappalainen J; Kovanen PT
J Allergy Clin Immunol; 2013 Aug; 132(2):463-9.e3. PubMed ID: 23582567
[TBL] [Abstract][Full Text] [Related]
7. Human intestinal fibroblasts prevent apoptosis in human intestinal mast cells by a mechanism independent of stem cell factor, IL-3, IL-4, and nerve growth factor.
Sellge G; Lorentz A; Gebhardt T; Levi-Schaffer F; Bektas H; Manns MP; Schuppan D; Bischoff SC
J Immunol; 2004 Jan; 172(1):260-7. PubMed ID: 14688333
[TBL] [Abstract][Full Text] [Related]
8. Novel six-week protocol for generating functional human connective tissue-type (MC
Tam IYS; Ng CW; Tam SY; Lau HYA
Inflamm Res; 2017 Jan; 66(1):25-37. PubMed ID: 27628164
[TBL] [Abstract][Full Text] [Related]
9. Mast cell activation and its relation to proinflammatory cytokine production in the rheumatoid lesion.
Woolley DE; Tetlow LC
Arthritis Res; 2000; 2(1):65-74. PubMed ID: 11219391
[TBL] [Abstract][Full Text] [Related]
10. Comparison of short term in vitro cultured human mast cells from different progenitors - Peripheral blood-derived progenitors generate highly mature and functional mast cells.
Andersen HB; Holm M; Hetland TE; Dahl C; Junker S; Schiøtz PO; Hoffmann HJ
J Immunol Methods; 2008 Jul; 336(2):166-74. PubMed ID: 18538784
[TBL] [Abstract][Full Text] [Related]
11. IL-4 and human skin mast cells revisited: reinforcement of a pro-allergic phenotype upon prolonged exposure.
Babina M; Guhl S; Artuc M; Zuberbier T
Arch Dermatol Res; 2016 Nov; 308(9):665-670. PubMed ID: 27650274
[TBL] [Abstract][Full Text] [Related]
12. Molecular mimicry in the chronic myeloproliferative disorders: reciprocity between quantitative JAK2 V617F and Mpl expression.
Moliterno AR; Williams DM; Rogers O; Spivak JL
Blood; 2006 Dec; 108(12):3913-5. PubMed ID: 16912229
[TBL] [Abstract][Full Text] [Related]
13. Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19.
Conti P; Caraffa A; Tetè G; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G
J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1629-1632. PubMed ID: 32945158
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of stem cell factor dependent formation of human mast cells by interleukin-3 and interleukin-4.
Sillaber C; Sperr WR; Agis H; Spanblöchl E; Lechner K; Valent P
Int Arch Allergy Immunol; 1994 Nov; 105(3):264-8. PubMed ID: 7522690
[TBL] [Abstract][Full Text] [Related]
15. Kinase drug discovery approaches in chronic myeloproliferative disorders.
Kumar C; Purandare AV; Lee FY; Lorenzi MV
Oncogene; 2009 Jun; 28(24):2305-13. PubMed ID: 19421140
[TBL] [Abstract][Full Text] [Related]
16. Human airway epithelial cell determinants of survival and functional phenotype for primary human mast cells.
Hsieh FH; Sharma P; Gibbons A; Goggans T; Erzurum SC; Haque SJ
Proc Natl Acad Sci U S A; 2005 Oct; 102(40):14380-5. PubMed ID: 16186496
[TBL] [Abstract][Full Text] [Related]
17. Predomination of IL-17-producing tryptase-positive/chymase-positive mast cells in azoospermic chronic testicular inflammation.
Chen SJ; Duan YG; Haidl G; Allam JP
Andrologia; 2016 Aug; 48(6):617-25. PubMed ID: 26420243
[TBL] [Abstract][Full Text] [Related]
18. The effects of anti-asthma drugs on mediator release from cultured human mast cells.
Shichijo M; Inagaki N; Nakai N; Kimata M; Nakahata T; Serizawa I; Iikura Y; Saito H; Nagai H
Clin Exp Allergy; 1998 Oct; 28(10):1228-36. PubMed ID: 9824389
[TBL] [Abstract][Full Text] [Related]
19. SOCS2: inhibitor of JAK2V617F-mediated signal transduction.
Quentmeier H; Geffers R; Jost E; Macleod RA; Nagel S; Röhrs S; Romani J; Scherr M; Zaborski M; Drexler HG
Leukemia; 2008 Dec; 22(12):2169-75. PubMed ID: 18769447
[TBL] [Abstract][Full Text] [Related]
20. The IgE- and calcium-dependent release of eicosanoids and histamine from human purified cutaneous mast cells.
Robinson C; Benyon C; Holgate ST; Church MK
J Invest Dermatol; 1989 Sep; 93(3):397-404. PubMed ID: 2504819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
